Article Text
Therapeutics
Systematic review
Large review finds no clinically important effect of glucosamine or chondroitin on pain in people with osteoarthritis of the knee or hip but results are questionable and likely due to heterogeneity
Statistics from Altmetric.com
Footnotes
-
Competing interests OB has received research funding for clinical studies on osteoarthritis, including studies of glucosamine/chondroitin by Galapagos, GSK, IBSA, Rottapharm and Servier and has been reimbursed for attending conferences where results have been presented.